Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Haoxi Health Technology Limited Class A ( (HAO) ) has shared an announcement.
On May 11, 2026, Haoxi Health Technology Limited entered into a securities purchase agreement with investors for a registered direct offering of 9,000,000 Class A ordinary shares at $0.25 per share and 16,999,998 pre-funded warrants, for gross proceeds of about $6.46 million before fees and expenses. The pre-funded warrants are immediately exercisable at $0.0026 per share and, in aggregate, are exercisable into up to 176,034,979 Class A shares, with the offering conducted under an effective F-3 shelf registration and subject to short-term issuance and variable-rate financing restrictions.
The offering closed on May 12, 2026, at which time Haoxi issued 146,445,353 Class A ordinary shares, including 9,000,000 new shares sold in the deal and 137,445,353 shares from the exercise of 13,273,332 pre-funded warrants, bringing its total outstanding share capital to 205,198,381 Class A and 690,800 Class B shares as of that date. Directors, officers, and major shareholders have agreed to 90-day lock-ups, and the company plans to use the net proceeds for working capital and general corporate purposes, meaning existing investors face notable dilution but the balance sheet gains additional liquidity to fund ongoing operations.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited is a Cayman Islands–incorporated company based in Beijing, China, whose Class A and Class B ordinary shares are listed and traded in the U.S. capital markets. The company operates in the broader health technology and services space, using equity capital markets financing to support its working capital and general corporate needs as it pursues growth initiatives.
Average Trading Volume: 11,531,007
Technical Sentiment Signal: Sell
Current Market Cap: $2.42M
Find detailed analytics on HAO stock on TipRanks’ Stock Analysis page.